Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01540682
Title MLN8237 in Head and Neck Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Abramson Cancer Center of the University of Pennsylvania
Indications

laryngeal squamous cell carcinoma

oral squamous cell carcinoma

pharynx squamous cell carcinoma

paranasal sinus cancer

Therapies

Alisertib + Cetuximab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.